T 0235/22 (Anti-CD47 dosage regimen/LELAND STANFORD JUNIOR UNIVERSITY) of 06.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T023522.20240606
- Date of decision
- 6 June 2024
- Case number
- T 0235/22
- Online on
- 15 July 2024
- Petition for review of
- -
- Application number
- 14768797.4
- IPC class
- C07K 16/28A61K 38/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for achieving therapeutically effective doses of anti-CD47 agents
- Applicant name
- The Board of Trustees of the Leland Stanford
Junior University - Opponent name
- König Szynka Tilmann von Renesse
Genmab A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 111(1)Rules of procedure of the Boards of Appeal Art 11
- Keywords
- Amendments - extension beyond the content of the application as filed (no)
Remittal - special reasons for remittal - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.